← Back
$HRTX All transactions

HERON THERAPEUTICS, INC. /DE/

A

$ Value

$0

Shares

53,960

Price

$0

Filed

Feb 3

Insider

Name

Morgan Adam

Title

CIK

0001964335

Roles

Director

Transaction Details

Transaction Date

2026-01-30

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

123,737

Footnotes

The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock. | Securities owned directly by Velan Capital Master Fund LP ("Velan Master"). Mr. Morgan, as a managing member of each of Velan Capital Holdings LLC, the general partner of Velan Master, and Velan Capital Management LLC, the general partner of the investment manager of Velan Master, may be deemed to beneficially own the securities owned directly by Velan Master. Mr. Morgan disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that Mr. Morgan is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Filing Info

Accession No.

0000921895-26-000200

Form Type

4

Issuer CIK

0000818033

Morgan Adam's History

Date Ticker Type Value
2026-01-30 HRTX A $0
2025-08-08 HRTX $2.6M
2025-08-08 HRTX $1.1M

Other Insiders at HRTX (90d)

Insider Bought Sold Last
Forbes William P
EVP, Chief Development Officer
2026-04-19
Collard Craig A
Chief Executive Officer
2026-04-19
Johnson Craig A 2026-01-30
Duarte Ira
EVP, Chief Financial Officer
2026-04-19
Christian Waage 2026-01-30
Kaseta Michael 2026-01-30
Dissanaike Sharmila 2026-01-30
Hensley Mark Earl
Chief Operating Officer
2026-01-30
Cusack Thomas 2026-01-30